An update on the genetics of schizophrenia

Current Opinion in Psychiatry

Volumn 19, Issue 2, 2006, Pages 158-164

  Norton, Nadine ^a   Williams, Hywel J ^a   Owen, Michael J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Association; DTNBP1; NRG1; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE; DEXTRO AMINO ACID OXIDASE ACTIVATOR; DYSBINDIN; ENZYME ACTIVATOR; GLUTAMATE RECEPTOR 3; METABOTROPIC RECEPTOR 3; NEU DIFFERENTIATION FACTOR; PROTEIN KINASE; REGULATOR PROTEIN; RGS4 PROTEIN; UNCLASSIFIED DRUG; AKT1 PROTEIN, HUMAN; CARRIER PROTEIN; DAO PROTEIN, HUMAN; DAOA PROTEIN, HUMAN; DEXTRO AMINO ACID OXIDASE; DTNBP1 PROTEIN, HUMAN; NERVE PROTEIN; NRG1 PROTEIN, HUMAN; PROTEIN KINASE B; RGS PROTEIN;

CHROMOSOMAL LOCALIZATION; CHROMOSOME 1Q; CHROMOSOME 22Q; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; DISEASE PREDISPOSITION; FOLLOW UP; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MOLECULAR GENETICS; NEUROBIOLOGY; POPULATION RESEARCH; REVIEW; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; THYMOMA; VELOCARDIOFACIAL SYNDROME; VIRUS ONCOGENE; ALLELE; CHROMOSOME 1; CHROMOSOME 22; GENETICS; METHODOLOGY; MOLECULAR BIOLOGY;

ALLELES; CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 22; D-AMINO-ACID OXIDASE; HUMANS; MOLECULAR BIOLOGY; NERVE TISSUE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RGS PROTEINS; SCHIZOPHRENIA;

EID: 33646824340     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yco.0000214341.52249.59     Document Type: Review

References (73)

1. Owen MJ, O'Donovan MC, Gottesman II. Schizophrenia. In: McGuffin P, Owen MJ, Gottesman II, editors. Psychiatric genetics and genomics. Oxford: Oxford Medical Publishers; 2002. pp. 247-266.
2. Gottesman II, Shields J. A polygenic theory of schizophrenia. Proc Natl Acad Sci U S A 1967; 58:199-145.
3. McGue M, Gottesman II. A single dominant gene still cannot account for the transmission of schizophrenia. Arch Gen Psychiatry 1989; 46:478-480.
4. Risch N. Genetic linkage and complex diseases, with special reference to psychiatric disorders. Genet Epidemiol 1990; 7:3-16.
5. Group SCL. Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6 and 8. Am J Med Genet 1996; 67:580-594.
6. Lewis CM, Levinson DF, Wise LH, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 2003; 73:34-48.
7. Straub RE, Jiang Y, MacLean CJ, et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71:337-348.
8. Schwab SG, Knapp M, Mondabon S, et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003; 72:185-190.
9. Morris DW, McGhee KA, Schwaiger S, et al. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study. Schizophr Res 2003; 60:167-172.
10. Van Den Bogaert A, Schumacher J, Schulze TG, et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet 2003; 73:1438-1443.
11. Numakawa T, Yagasaki Y, Ishimoto T, et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 2004; 13:2699-2708. This study shows the positive allelic and haplotypic association in 670 patients with schizophrenia and 588 controls from Japan and functional evidence for the role of DTNBP1 in neuronal viability.
12. Tang JX, Zhou J, Fan JB, et al. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry 2003; 8:717-718.
13. Funke B, Finn CT, Plocik AM, et al. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am J Hum Genet 2004; 75:891-898. Positive association of DTNBP1 with schizophrenia in a large case-control sample collected from the US is described in this study. The samples consisted of a subset of 258 Caucasian patients and 467 controls and smaller subsets of African Americans and Hispanics. This paper provides an excellent summary of the different haplotypic associations observed in the DTNBP1 literature.
14. Kirov G, Ivanov D, Williams NM, et al. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiatry 2004; 55:971-975.
15. Williams NM, Preece A, Morris DW, et al. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry 2004; 61:336-344.
16. Talbot K, Eidem WL, Tinsley CL, et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 2004; 113:1353-1363.
17. Weickert CS, Straub RE, McClintock BW, et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 2004; 61:544-555.
18. Bray NJ, Buckland PR, Owen MJ, O'Donovan MC. Cis-acting variation in the expression of a high proportion of genes in human brain. Hum Genet 2003; 113:149-153.
19. Bray NJ, Preece A, Williams NM, et al. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum Mol Genet 2005; 14:1947-1954. This study uses allelic expression assays to examine DTNBP1 mRNA levels. In concordance with Weickert et al. [17], the authors found that reduced DTNBP1 expression is associated with the same polymorphism in the 30-UTR. This study also shows that a defined schizophrenia risk haplotype in DTNBP1 and risk haplotypes identified in other sample groups tag cis-acting variants that results in a relative reduction of DTNBP1 mRNA.
20. Stefansson H, Sigurdsson E, Steinthorsdottir V, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71:877-892.
21. Stefansson H, Sarginson J, Kong A, et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003; 72:83-87.
22. Williams NM, Preece A, Spurlock G, et al. Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry 2003; 8:485-487.
23. Corvin AP, Morris DW, McGhee K, et al. Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the neuregulin-1 locus. Mol Psychiatry 2004; 9:208-213.
24. Yang JZ, Si TM, Ruan Y, et al. Association study of neuregulin 1 gene with schizophrenia. Mol Psychiatry 2003; 8:706-709.
25. Tang JX, Chen WY, He G, et al. Polymorphisms within 50 end of the neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Mol Psychiatry 2004; 9:11-12.
26. Zhao X, Shi Y, Tang J, et al. A case control and family based association study of the neuregulin1 gene and schizophrenia. J Med Genet 2004; 41:31-34.
27. Hall D, Gogos JA, Karayiorgou M. The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav 2004; 3:240-248.
28. Iwata N, Suzuki T, Ikeda M, et al. No association with the neuregulin 1 haplotype to Japanese schizophrenia. Mol Psychiatry 2004; 9:126-127.
29. Thiselton DL, Webb BT, Neale BM, et al. No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF). Mol Psychiatry 2004; 9:777-783.
30. Hong CJ, Huo SJ, Liao DL, et al. Case-control and family-based association studies between the neuregulin 1 (Arg38Gln) polymorphism and schizophrenia. Neurosci Lett 2004; 366:158-161.
31. Green EK, Raybould R, Macgregor S, et al. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry 2005; 62:642-648. This study is of particular interest because the authors found significant association with the originally associated NRG1 Icelandic core risk haplotype with bipolar disorder. Their analyses also found a more significant association with those patients with predominantly mood incongruent psychotic features and a small subset of schizophrenia patients with mania.
32. Chumakov I, Blumenfeld M, Guerassimenko O, et al. Genetic and physiological data implicating the newhuman gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 2002; 99:13675-13680.
33. Korostishevsky M, Kaganovich M, Cholostoy A, et al. Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol Psychiatry 2004; 56:169-176.
34. Addington AM, Gornick M, Sporn AL, et al. Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol Psychiatry 2004; 55:976-980.
35. Schumacher J, Jamra RA, Freudenberg J, et al. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 2004; 9:203-207.
36. Zou F, Li C, Duan S, et al. A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population. Schizophr Res 2005; 73:257-261. Positive association of individual markers and haplotypes at the DAOA (G72) locus with schizophrenia in 233 Chinese trios is described in this study.
37. Korostishevsky M, Kremer I, Kaganovich M, et al. Transmission disequilibrium and haplotype analyses of the G72/G30 locus: suggestive linkage to schizophrenia in Palestinian Arabs living in the North of Israel. Am J Med Genet B Neuropsychiatr Genet 2005 [Epub ahead of print]. The authors of this study genotyped 11 SNPs across the DAOA (G72) locus in a sample of 233 Palestinian Arab families. The same markers were previously genotyped by this group in a small sample of Ashkenazi Jews. Both studies showed significant association with schizophrenia, but in Palestinian Arabs, significant association was observed with a single SNP, with ∼8 kb from the associated linkage disequilibrium block in the Ashkenazi sample and with an adjacent haplotype.
38. Hattori E, Liu C, Badner JA, et al. Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet 2003; 72:1131-1140.
39. Chen YS, Akula N, Detera-Wadleigh SD, et al. Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33. Mol Psychiatry 2004; 9:87-92.
40. Williams NM, Green EK, MacGregor S, et al. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry (in press).
41. Mirnics K, Middleton FA, Stanwood GD, et al. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 2001; 6:293-301.
42. Chowdari KV, Mirnics K, Semwal P, et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 2002; 11:1373-1380.
43. Williams NM, Preece A, Spurlock G, et al. Support for RGS4 as a susceptibility gene for schizophrenia. Biol Psychiatry 2004; 55:192-195.
44. Chen X, Dunham C, Kendler S, et al. Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am J Med Genet B Neuropsychiatr Genet 2004; 129:23-26.
45. Morris DW, Rodgers A, McGhee KA, et al. Confirming RGS4 as a susceptibility gene for schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004; 125:50-53.
46. Sobell JL, Richard C, Wirshing DA, Heston LL. Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians. Am J Med Genet B Neuropsychiatr Genet 2005; 139:23-27. This study reports no association with any single marker or haplotype in RGS4 in a large Caucasian sample of 568 schizophrenic patients and 689 controls.
47. Cordeiro Q, Talkowski ME, Chowdari KV, et al. Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil. Genes Brain Behav 2005; 4:45-50. Failure to detect allelic or haplotypic association of RGS4 with schizophrenia in 271 schizophrenic patients and 576 controls from Brazil is reported in this study.
48. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56:940-945.
49. Ivanov D, Kirov G, Norton N, et al. Chromosome 22q11 deletions, velo-cardiofacial syndrome and early-onset psychosis. Molecular genetic study. Br J Psychiatry 2003; 183:409-413.
50. Blackwood DH, Fordyce A, Walker MT, et al. Schizophrenia and affective disorders - cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001; 69:428-433.
51. Lachman HM, Papolos DF, Saito T, et al. Human catechol O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6:243-250.
52. Chen J, Lipska BK, Halim N, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004; 75:807-821. The common coding SNP in COMT, Val158Met, has been the subject of many association studies with schizophrenia. In this study, the Val158Met variant was shown to significantly effect COMT protein abundance.
53. Munafo MR, Bowes L, Clark TG, Flint J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry 2005; 10:765-770. This is the most recent meta-analysis of the COMT Val158Met polymorphism with schizophrenia in case-control samples. The analyses encompass data from 18 studies, nine of which are of European ancestry. The analyses do not support association of schizophrenia with Val158Met.
54. Williams HJ, Glaser B, Williams NM, et al. No association between schizophrenia and polymorphisms in COMT in two large samples. Am J Psychiatry 2005; 162:1736-1738. Following the reports of strong haplotypic association of COMT in Ashkenazi Jewish and Irish subjects, the authors of this study attempted replication. In both, a UK-based case-control sample of 709 schizophrenic patients and 710 controls and a second independent sample of 488 parent-proband trios from Bulgaria, the authors found no evidence for association of schizophrenia with the COMT gene with any single marker or haplotype and no association with gender.
55. Sanders AR, Rusu I, Duan J, et al. Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia. Mol Psychiatry 2005; 10:353-365. This study includes data from eight markers spanning not only the COMT gene but also the adjacent genes, TR2 and ARVCF. Analyses in 136 schizophrenia families showed association with a three-marker haplotype spanning COMT and ARVCF suggesting that ARVCF may also contribute to schizophrenia susceptibility.
56. Mukai J, Liu H, Burt RA, et al. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat Genet 2004; 36:725-731.
57. Chen WY, Shi YY, Zheng YL, et al. Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8. Hum Mol Genet 2004; 13:2991-2995. Following the initial report of association of ZDHHC8 with schizophrenia [56], the authors of this study performed association analyses with rs175174 in 465 schizophrenia patients and 467 controls and a 158 parent-proband trios of Han Chinese origin. The authors found significant association with rs175174 allele G in both samples, contrary to the original positive study [56].
58. Glaser B, Schumacher J, Williams HJ, et al. No association between the putative functional ZDHHC8 single nucleotide polymorphism rs175174 and schizophrenia in large European samples. Biol Psychiatry 2005; 58:78-80. In the largest study to date of rs175174 in ZDHHC8, association analyses of 474 parent-offspring trios from Bulgaria and three case-control samples of European origin (1028 cases/1253 controls) showed no evidence for association with schizophrenia or the presence of gender-specific differences.
59. Otani K, Ujike H, Tanaka Y, et al. The ZDHHC8 gene did not associate with bipolar disorder or schizophrenia. Neurosci Lett 2005; 390:166-170. In this study, 407 schizophrenia patients and 497 controls of Japanese origin showed no evidence for association of rs175174 in ZDHHC8 with schizophrenia or the presence of gender-specific differences. The same analyses were also negative with bipolar disorder and when the sample of schizophrenia patients was classified into paranoid and disorganized types.
60. Thomson PA, Wray NR, Millar JK, et al. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol Psychiatry 2005; 10:657-668; 616. This is a comprehensive and systematic study across the TRAX/DISC locus. Association analyses in 394 schizophrenic, 381 bipolar cases and 478 controls showed significant association with both schizophrenia and bipolar disorder.
61. Hodgkinson CA, Goldman D, Jaeger J, et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 2004; 75:862-872. In this paper, analyses of a Caucasian case-control sample of 196 schizophrenic, 82 bipolar, 62 schizoaffective patients and 217 controls from North America showed that a common haplotype is associated with schizoaffective disorder. This study supports the hypothesis that the DISC1 locus predisposes to a variety of psychiatric disorders and that schizophrenia and bipolar disorder may have convergent aetiology.
62. Callicott JH, Straub RE, Pezawas L, et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A 2005; 102:8627-8632. In this study, the authors found evidence for association with schizophrenia of a three-marker haplotype and nominal significance with a single SNP in DISC1. The same SNP is also associated with hippocampal structure and function in control subjects.
63. Zhang X, Tochigi M, Ohashi J, et al. Association study of the DISC1/TRAX locus with schizophrenia in a Japanese population. Schizophr Res 2005; 79:175-180. In this study of a Japanese sample of 338 cases and 338 controls, the authors found no evidence of association of allelic or haplotypic association with 15 SNPs across the TRAX/DISC1 locus.
64. Kockelkorn TT, Arai M, Matsumoto H, et al. Association study of polymorphisms in the 50 upstream region of human DISC1 gene with schizophrenia. Neurosci Lett 2004; 368:41-45.
65. Emamian ES, Hall D, Birnbaum MJ, et al. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 2004; 36:131-137.
66. Ohtsuki T, Inada T, Arinami T. Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population. Mol Psychiatry 2004; 9:981-983. This study performed association analysis across the AKT1 gene with the same marker set used by Emamian et al. [65] in the initial positive association. The authors found no allelic or haplotypic association in a Japanese sample of 559 schizophrenic patients and 567 controls.
67. Ikeda M, Iwata N, Suzuki T, et al. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol Psychiatry 2004; 56:698-700. In this study, the authors performed association analyses across AKT1 with the same marker set used by Emamian et al. [65] in the initial positive association and an additional SNP at the 30′-end of the gene. Different haplotypes were significantly associated compared with those of the initial positive study [65] in 507 Japanese patients and 437 controls.
68. Schwab SG, Hoefgen B, Hanses C, et al. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry 2005; 58:446-450. In this study, the authors performed association analyses across AKT1 with the same marker set used by Emamian et al. [65] in the initial positive association and two additional SNPs. Significant association was observed with single markers and with haplotypes, including the same haplotype associated in Emamian et al. [65].
69. Marti SB, Cichon S, Propping P, et al. Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population. Am J Med Genet 2002; 114:46-50.
70. Fujii Y, Shibata H, Kikuta R, et al. Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet 2003; 13:71-76.
71. Egan MF, Straub RE, Goldberg TE, et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A 2004; 101:12604-12609.
72. Chen Q, He G, Wu S, et al. A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population. Schizophr Res 2005; 73:21-26. The authors showed positive allelic and haplotypic association of GRM3 with a large Chinese sample of 752 schizophrenic patients and 752 controls. It is, however, difficult to compare significance with other studies of GRM3 as only one marker is typed in common between this study and the study of Egan et al. [71].
73. Norton N, Williams HJ, Dwyer S, et al. No evidence for association between polymorphisms in GRM3 and schizophrenia. BMC Psychiatry 2005; 5:23. This is a replication study of Egan et al. [71] which examines the same marker set in a large UK-based case-control sample of 674 schizophrenic patients and 716 controls. No allelic or haplotypic association is observed with any markers.